Relationship between insulin resistance and nonmodulating hypertension: Linkage of metabolic abnormalities and cardiovascular risk

Diabetes

Volumn 48, Issue 8, 1999, Pages 1623-1630

  Ferri, Claudio ^a   Bellini, Cesare ^a   Desideri, Giovambattista ^a   Valenti, Marco ^c   De Mattia, Giancarlo ^a   Santucci, Anna ^c   Hollenberg, Norman K ^b   Williams, Gordon H ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Brigham and Women's Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RENIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARBOHYDRATE METABOLISM; CARDIOVASCULAR RISK; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SODIUM BALANCE; SODIUM TRANSPORT;

NON-PROGRAMMATIC;

ADULT; ANTIPORTERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIET; ERYTHROCYTES; FASTING; GLUCOSE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MEDICAL RECORDS; MIDDLE AGED; RISK FACTORS; SODIUM;

EID: 0032765035     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.8.1623     Document Type: Article

References (59)

1. M. Modan , Halkin H, Halmog S, Luski A, Eshkil A, Shefi M, Shitrit A, Fuchs A: Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 75:809-816, 1985
2. Ferrannini E, Haffner SM, Stern M: Essential hypertension: an insulin-resistant state. J Cardiovasc Pharmacol 15:S18-S25, 1992
3. Alderman M, Madahavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH: Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Mod 324:1098-1104, 1991
4. Laragh JH, Sealey JE: The renin-angiotensin-aldosterone system in hypertensive disorders: a key to two forms of arteriolar vasoconstriction and a possible clue to risk of cardiovascular injury (heart attack and stroke) and prognosis. In Hypertension: Pathophysiology, Diagnosis, and Management. Laragh JH, Brenner BM, Eds. New York, Raven, 1990, p. 1329-1348
5. Shoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK: Defect in the sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest 72:2155-2124, 1983
6. Hollenberg NK, Williams GH: Abnormal renal function, sodium-volume homeostasis, and renin system behavior in normal-renin essential hypertension. In Hypertension: Pathogenesis, Diagnosis, and Management. Laragh JH, Brenner BM, Eds. New York, Raven, 1995, p. 1837-1856
7. Williams GH, Dluhy RG, Lifton RP, Moore TJ, Gleason R, Williams RR, Hunt SC, Hopkins PN, Hollenberg NK Nonmodulation as an intermediate pheno-type in essential hypertension. Hypertension 20:788-796, 1992
8. Blackshear JL, Garnic D, Williams GH, Harrington DP, Hollenberg NK: Exaggerated renal vasodilator response to calcium entry blockade in first-degree relatives of essential hypertensive subjects. Hypertension 9:384-389, 1987
9. Berretta-Piccoli C, Psterla C, Stadler P, Weidman R Blunted aldosterone responsiveness to angiotensin II in normotensive subjects with familial predisposition to essential hypertension. J Hypertens 6:57-61, 1988
10. Lifton RP, Hopkins PN, Williams RR, Hollenberg NK, Williams GH, Dluhy RG: Evidence for heritability of nonmodulating essential hypertension. Hypertension 13:884-389, 1989
11. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin M-C, Skuppin J, Williams CS, Dluhy RG, Lalouel J-M, Williams RR, Williams GH: Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 14:199-207, 1996
12. Redgrave J, Canessa M, Gleason R, Hollenberg NK, Williams GH: Red blood cell lithium-sodium countertransport in nonmodulating essential hypertension. Hypertension 13:721-726, 1989
13. Gaboury CL, Hollenberg NK, Hopkins PN, Williams R, Williams GH: Metabolic derangements in nonmodulating hypertension. Am J Hypertens 8:870-875, 1995
14. Leonetti Luparini R, Ferri C, Santucci A, Balsano F: Atrial natriuretic peptide in nonmodulating essential hypertension. Hypertension 21:803-809, 1993
15. DeFronzo RA: Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. J Cardiovasc Pharmacol 20:S1-S15, 1992
16. Yap L, Arrazola A, Soria F, Diez J: Is there increased cardiovascular risk in essential hypertensive patients with abnormal kinetics of red blood cell sodium-lithium countertransport? J Hypertens 7:667-673, 1989
17. Morgan DB, Stewart AD, Davidson C: Relations between erythrocyte lithium efflux, blood pressure, and family histories of hypertension and cardiovascular disease: studies in a factory workforce and hypertension clinic. J Hypertens 4:609-615, 1986
18. Ferri C, Desideri G: Terapia del paziente iperteso insulinoresistente. In Ipertensione e Metabolismo Degli Idrati di Carbonio. Ferri C, Ed. Padua, Italy, Piccin, 1994, p. 97-106
19. Anderson JW, Briant CA: Dietary fiber diabetes and obesity. Am J Gastroenterol 81:898-906, 1986
20. Donovan DS, Solomon CG, Seely EW, Williams GH, Simonson DC: Effect of sodium intake on insulin sensitivity. Am J Physiol 264:E730-E734, 1993
21. Ferri C, Bellini C, Baldoncini R, Leonetti Luparini R, Perrone A, Santucci A: Abnormal atrial natriuretic peptide and renal responses to saline infusion in nonmodulating essential hypertensive patients. Circulation 90:2859-2869, 1994
22. Redgrave JE, Rabinowe SL, Hollenberg NK, Williams GH: Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensive subjects. J Clin Invest 75:1285-1290, 1985
23. Friedewald WT, Levy RI, Frederickson DS: Estimation of the concentration of LDL cholesterol without the use of preparative ultracentrifugation. Clin Chem 18:499-502, 1978
24. Hollenberg NK, Moore TJ, Shoback D, Redgrave J, Rabinowe S, Williams GH: Abnormal renal sodium handling in essential hypertension: relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med 81:412-418, 1986
25. Williams GH, Hollenberg NK: Nonmodulating hypertension: a subset of sodium-sensitive hypertension. Hypertension 17:181-185, 1991
26. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R: Insulin resistance in essential hypertension. N Engl J Med 317:350-357, 1987
27. Pollare T, Lithell H, Berne C: Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism 39:167-174, 1990
28. Sanchez RA, Gimenez MI, Migliorini M, Giannone C, Ramirez AJ, Weder AB: Erythrocyte sodium-lithium countertransport in nonmodulating offspring and essential hypertensive individuals: response to enalapril. Hypertension 30:99-105, 1997
29. Hunt SC, Williams RR, Smith JB, Ash KO: Association of three red blood cell cation transport systems with plasma lipids in Utah subjects. Hypertension 8:30-36, 1986
30. Hasstedt SJ, Wu LL, Ash KO, Kuida H, Williams RR: Hypertension and sodium-lithium countertransport in Utah pedigrees: evidence for a major-locus inheritance. Am J Hum Genet 43:14-22, 1988
31. Carr SJ, Thomas TH, Laker MF, Wilkinson R: Elevated sodium-lithium countertransport: a familial marker of hyperlipidemia and hypertension? J Hypertens 8:139-146, 1988
32. Doria A, Fiotetto P, Avogaro A: Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 261:E684-E691, 1991
33. Nosadini R, Semplicini A, Fioertto P, Lusiani L, Trevisan R, Donadon V, Zanette G, Nicolosi GL, Dall'Aglio V, Zanuttini D, Viberti GC: Sodium-lithium countertransport and cardiorenal abnormalities in essential hypertension. Hypertension 18:191-198, 1991
34. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
35. Beck-Nielson H: Clinical disorders in insulin resistance. In International Textbook of Diabetes Mellitus. Alberti KGMM, DeFronzo RA, Keen H, Zinnet P, Eds. West Sussex, U.K., Wiley 1992, p. 467-511
36. Reaven GM: Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988
37. Hollenbeck C, Reaven GM: Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64:1169-1173, 1987
38. Hollenberg NK, Moore TJ, Shoback D, Redgrave J, Rabinowe S, Williams GH: Abnormal renal sodium handling in essential hypertension: relation to failure of renal and adrenal modulation of responses to angiotensin II. Am J Med 81:412-418, 1986
39. Redgrave JE, Rabinowe SL, Hollenberg NK, Williams GH: Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensive subjects. J Clin Invest 75:1285-1290, 1985
40. Stier CT, Benter IF, Ahmad S, Zuo H, Selig N, Roethel S, Levine S, Itskowitz HD: Enalapril prevents stroke and kidney dysfunction in salt-loaded stroke-prone spontaneously hypertensive rats. Hypertension 13:115-121, 1989
41. + feeding in stroke-prone hypertensive rats. Hypertension 15:318-326, 1990
42. Townsend RA, Zhao H: Plasma renin activity and insulin sensitivity in normotensive subjects. Am J Hypertens 7:894-898, 1994
43. Egan BM, Stepniakowski K, Goodfriend TL: Renin and aldosterone are higher and the hyperlipidemic effect of salt restriction greater in subjects with risk factor clustering. Am J Hypertens 7:886-893, 1994
44. Sharma AM, Rutland K, Spies KP, Distler A: Salt sensitivity in young normotensive subjects is associated with a hyperinsulinemic response to oral glucose. J Hypertens 9:329-335, 1991
45. Sharma AM, Schorr U, Distler A: Insulin resistance in young salt-sensitive normotensive subjects. Hypertension 21:273-279, 1993
46. DeFronzo R: The effect of insulin on renal sodium metabolism: a review with clinical implications, Diabetotogia 21:165-171, 1981
47. Anderson EA, Hoffman RP, Baion TW, Sinkey CA, Mark AL: Hyperinsulinemia produces both sympathetic activation and vasodilation in normal humans. J Clin Invest 87:2246-2252, 1991
48. DiBona GF: Neurogenic regulation of renal tubular sodium reabsorption. Am J Physiol 233:F73-F81, 1977
49. Hollenberg NK: The renin-angiotensin system and sodium homeostasis. J Cardiovasc Pharmacol 6:176-183, 1984
50. Faulkner B, Hulman S, Kushner H: Hyperinsulinemia and blood pressure sensitivity to sodium in young blacks. J Am Soc Nephrol 3:940-946, 1992
51. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 321:580-585, 1989
52. Lind L, Lithel H, Gustaffson IB, Pollare T, Ljunghall S: Metabolic cardiovascular risk factors and sodium sensitivity in hypertensive subjects. Am J Hypertens 5:502-505, 1992
53. Gans RO, Bilo HJ, von Maarschalkerweerd WW, Heine RJ, Nauta JJ, Donker AJ: Exogenous insulin augments in healthy volunteers the cardiovascular reactivity to noradrenaline but not to angiotensin II. J Clin Invest 88:512-518, 1991
54. Egan BM, Stepniakowski K, Nazzaro P: Insulin levels are similar in obese salt-sensitivity and salt-resistant subjects. Hypertension 23:11-17, 1994
55. Gaboury CL, Simonson DC, Seely EW, Hollenberg NK, Williams GH: Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest 94:2295-2300, 1994
56. Iyer SN, Katovich MJ: Vascular reactivity to phenylephrine and angiotensin II in hypertensive rats associated with insulin resistance. Clin Exp Hypertens 18:227-242, 1996
57. Reaven GM: Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia, and coronary heart disease. Am Heart J 21: 1283-1288, 1991
58. Berne C, Pollare T, Lithell H: Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care 14:39-47, 1991
59. Thurig C, Bohlen L, Schneider M, de Courten M, Shaw SG, Riesen W, Weidmann P: Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients. Eur J Clin Pharmacol 49:21-26, 1995